News
Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...
Continuous processing is a well-known technique for (mAb production, but has only begun attracting interest in AAV production.
Ph.D., an investigator at the Gene and Cell Therapy Institute (GCTI) at Mass General Brigham and Engineering in Medicine ...
A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...
Cell and gene therapy manufacturers that adopt automated bioprocessing technologies are likely to use AI in QA/QC and batch release.
How collaborative partnerships are driving progress in transformative cell and gene therapies (CGTs)
The latest trends in cell therapies indicate a growing confidence in their effectiveness, an expansion of applications beyond ...
Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of sickle cell gene therapy ...
Precise CRISPR-Cas 9 editing provides a scaleable engineering ... multiplex gene editing leads to the KO of all HLA alleles ...
Director, Paediatrics, Jaslok Hospital & Research Centre explains how stem cell therapy and regenerative medicine have the ...
The global CAR T-cell therapy market is on track for rapid growth, with projections indicating it will exceed USD 27.5 billion by 2033, up from USD 2.7 billion in 2025. This exponential rise in market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results